SIRPa1 macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

Mario L. Marques-Piubelli, Edwin R. Parra, Lei Feng, Luisa Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B Hagemeister, Jason R. Westin, Hun Ju Lee, Maria A. Rodriguez, Sattva S. Neelapu, Jillian R. Gunther, Nathan H. Fowler, Christopher R. Flowers, Ignacio I. Wistuba, Loretta J. Nastoupil, Francisco Vega, Paolo Strati

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'SIRPa1 macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab'. Together they form a unique fingerprint.

Medicine & Life Sciences